2.700
+0,00%
2026-10-19
Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -68.6% | +7.9% | 1 / 3 | -21.8% | +0.45 pp | -1.15 pp | +1.7% | 1.03 | 13.18 | 222 | −21,8% | 1,7 | −68,6% | 13.18 | 25.19 | −47,7% |
| Pts | 0 | 0 | 4 | 0 | 8 | 4 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 2.700 (close price on 2026-10-19)EPS (TTM): 204,9
Financial charts
1.Revenue & growth
VND bn222Q2/26
1.Revenue & growth
VND bn222Q2/26
2.Profit & growth
VND bn1,90Q2/26
3.Profit mix (Penman)
VND bn13,8Q2/26
4.Margins & cost structure
%10.0%Q2/26
5.Returns & cash cycle
% · days3.4%Q2/26
6.Earnings quality & cash
VND bn34,2Q2/26
7.Asset structure
VND bn1.557Q2/26
8.Funding & debt health
VND bn · times1.557Q2/26
9.Revenue backlog
VND bn6,27Q2/26
10.Valuation
times · %13,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %33Q2/26
Adjusted EPS growth, latest quarter
-65.1%
Average adjusted EPS growth, 3 quarters
-52.6%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26